Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Janus Henderson Group PLC reported a 9.99% stake in Lexeo Therapeutics, Inc. (Schedule 13G/A)
Event Nov 28, 2025 · Filed Dec 8, 2025
Janus Henderson Group PLC reported a 9.99% stake in Lexeo Therapeutics, Inc., 7,291,434 shares, as a passive investor on Nov 28, 2025. Filed Dec 8, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 7,291,434
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 9.99% | 7,291,434 |
Source
Related
- Lexeo Therapeutics, Inc.
- Janus Henderson Group PLC
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Nov 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · May 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Feb 14, 2025
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026